Blue Water Life Science Advisors’s Natera NTRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.1M | Sell |
166,494
-42,000
| -20% | -$7.1M | 22.26% | 1 |
|
|
2025
Q1 | $29.5M | Sell |
208,494
-46,300
| -18% | -$6.55M | 29.22% | 2 |
|
|
2024
Q4 | $40.3M | Sell |
254,794
-36,300
| -12% | -$5.75M | 35.71% | 1 |
|
|
2024
Q3 | $37M | Sell |
291,094
-212,000
| -42% | -$26.9M | 32.5% | 1 |
|
|
2024
Q2 | $54.5M | Hold |
503,094
| – | – | 52.98% | 1 |
|
|
2024
Q1 | $46M | Buy |
503,094
+105,658
| +27% | +$9.66M | 43.28% | 1 |
|
|
2023
Q4 | $24.9M | Sell |
397,436
-400,000
| -50% | -$25.1M | 21.81% | 1 |
|
|
2023
Q3 | $35.3M | Sell |
797,436
-84,000
| -10% | -$3.72M | 33.31% | 1 |
|
|
2023
Q2 | $42.9M | Hold |
881,436
| – | – | 28.95% | 1 |
|
|
2023
Q1 | $48.9M | Hold |
881,436
| – | – | 32.36% | 1 |
|
|
2022
Q4 | $35.4M | Sell |
881,436
-223,145
| -20% | -$8.96M | 23.79% | 1 |
|
|
2022
Q3 | $48.4M | Buy |
1,104,581
+175,000
| +19% | +$7.67M | 19.54% | 2 |
|
|
2022
Q2 | $32.9M | Sell |
929,581
-198,400
| -18% | -$7.03M | 17.89% | 2 |
|
|
2022
Q1 | $45.9M | Buy |
1,127,981
+405,800
| +56% | +$16.5M | 21.78% | 1 |
|
|
2021
Q4 | $67.4M | Buy |
722,181
+168,800
| +31% | +$15.8M | 20.63% | 1 |
|
|
2021
Q3 | $61.7M | Buy |
553,381
+95,400
| +21% | +$10.6M | 20.06% | 1 |
|
|
2021
Q2 | $52M | Buy |
457,981
+129,145
| +39% | +$14.7M | 19.56% | 1 |
|
|
2021
Q1 | $33.4M | Buy |
328,836
+44,035
| +15% | +$4.47M | 16.31% | 3 |
|
|
2020
Q4 | $28.3M | Buy |
+284,801
| New | +$28.3M | 16.64% | 2 |
|